Example collocations logo

Screening in sentence

622 examples of Screening in a sentence

You may recall a year ago when a firestorm erupted after the United States Preventive Services Task Force reviewed the world's mammography screening literature and issued a guideline recommending against screening mammograms in women in their 40s.
Screening the average young woman with an MRI is kind of like driving to the grocery store in a Hummer.
And we were elated when they took a chance on a team of completely unknown investigators and funded us to study 1,000 women with dense breasts, comparing a screening mammogram to an MBI.
Here's an example from that screening study.
And at this low dose, we're continuing this screening study, and this image from three weeks ago in a 67-year-old woman shows a normal digital mammogram, but an MBI image showing an uptake that proved to be a large cancer.
We still need to complete the screening study using the low dose, and then our findings will need to be replicated at other institutions, and this could take five or more years.
So it takes 10 or more years for any screening method to demonstrate a reduction in mortality from breast cancer.
We need to individualize screening based on density.
But for women with dense breasts; we shouldn't abandon screening altogether, we need to offer them something better.
Then we can try to do things in vivo that have only been done to date in a dish, like high-throughput screening throughout the entire brain for the signals that can cause certain things to happen or that could be good clinical targets for treating brain disorders.
I won't ask who here's had a colonoscopy, but if you're over age 50, it's time for your screening colonoscopy.
So we organized a screening.
We need to be able to really go from universal screening to universal access to treatment, because those treatments are going to change these children's and those families' lives.
Because when these people get home after a screening of "Rear Window" and raise their gaze to the building next door, they have the tools to wonder who, apart from them, is out there and what is their story.
It's basically a little health care screening tool that we developed.
How do we empower her with simple tools that's not diagnostic but more screening in nature so she at least knows how to advise the patients better?
So that was a very simple three-step screening process that could basically change the equation of how public health care works in so many different ways.
When I showed it, and I asked, immediately after the screening was over, what they thought of it, what was your memorable shots, they changed them.
RL: So, what I did is basically I had another screening room experience where I was basically tracking where I was looking, or where we were looking, and of course you're looking at the two people on the bow of the ship, and then at some point, I'm changing the periphery of the shot, I'm changing, it's becoming the rusted wreck, and then I would run it every day, and then I would find exactly the moment that I stopped looking at them and start noticing the rest of it, and the moment my eye shifted, we just marked it to the frame.
We can perform low-cost mass recruitment for clinical trials, and we can make population-scale screening feasible for the first time.
For the first time, we are merging telemedicine with mobile screening technology that extends the reach of expert triage beyond health care settings.
If I were screening Anuk at school, sound-attenuating headphones and noise monitoring would take the place of a sound booth, and I would use a phone adapter instead of a microscope to examine his ears.
In a matter of minutes, screening and images are done.
So what we did was, we created a global action plan, and we're taking 10 percent of what's raised in each country now and putting it into a global fund, and we've got the best prostate cancer scientific minds in the world that look after that fund, and they come together each year and identify the number one priority, and that, last year, was getting a better screening test.
Well, let's think about the drug screening process for a moment.
And so thinking about the models that we've just discussed, you can see, going forward, that tissue engineering is actually poised to help revolutionize drug screening at every single step of the path: disease models making for better drug formulations, massively parallel human tissue models helping to revolutionize lab testing, reduce animal testing and human testing in clinical trials, and individualized therapies that disrupt what we even consider to be a market at all.
He was not invited to the screening.
All that screening occurs in animal models.
And the crucial point about this is that you then have a fantastic assay to discover drugs, because what would you ask of the drugs, and you could do this through a high-throughput automated screening system, you'd ask the drugs, give me one thing: find me a drug that will bring the red line closer to the blue line, because that drug will be a high-value candidate that you could probably take direct to human trial and almost bypass that bottleneck that I've told you about in drug discovery with the animal models, if that makes sense.
Six months ago, we locked down the screening key for this decoder.
Next